Argenta Bags Respiratory-focused Discovery Deal with Boehringer Ingelheim
Argenta has won a discovery services contract with German drugmaker Boehringer Ingelheim (BI).
Archives for April 23, 2013
Live from Interphex
Regulatory and Financial Burdens Slow IR/MR Approvals, Says Expert
Efforts to update SUPAC guidance on immediate and modified release dosage forms will end in faster approvals, if regulatory and financial hurdles can be overcome, says expert.
DSM Opens Australian Government Backed Biologics Facility
With backing from the Australian Government, DSM has opened a mammalian cell culture operation to fuel the growing demand in the Asia-Pacific biologics market.
Live from Interphex
IHolland Talks Tabletting Solutions for Sticky Formulations
IHolland says tableting-focused research project will save customers time and money.
Live from Interphex
Experts: Real-Time Release Testing Desirable But Not Primary Goal of QbD
The US FDA is beginning to push CMOs and other manufacturers away from using real-time release testing as a shortcut to ensuring drug quality and reducing end product testing, experts said.
Live from Interphex
Almac Talks Facility Expansions on Both Sides of the Atlantic
Almac says $10m investment at its recently expanded facility in Northern Ireland compliments the sites existing formulation development capabilities.